Menu Back to SEE-South-Eastern-Europe-Region-Workshop


This conference is especially designed to connect regulatory and market access experts working with and/or in the South-Eastern Europe region with key regional, EU and global Leaders, including Regulators, Payers, Patients, in a neutral forum dedicated to accelerating patients’ access. We will discuss topics such as the existing access gap between the region and the EU and the importance of reliance for faster access, considering a closer alignment with the EU regulatory framework.

Back in a face-to-face format, this conference will provide a unique opportunity to learn from best practice examples and to network with regulators and key leaders from all across Europe.

Key Topics in Regulatory Affairs & Policy

  • Regulatory Convergence, Reliance and Collaboration
  • How to increase Stakeholders’ dialogue across countries and regions
  • Regulatory flexibilities and agilities during the COVID-19 pandemic
  • Digitalisation and new technologies

Key Topics in Market Access

  • Exploring Innovation in Managed Entry Agreements
  • Investment in healthcare: return on investment and healthy population
  • Addressing inequalities and improving access to innovation

Who should attend?

Professionals involved in:

  • Regulatory Affairs
  • Regional Regulatory Development
  • Regulatory Submissions
  • Policy & Intelligence
  • Market Access
  • Patient Engagement
  • Patient Advocates
  • Health Authorities
  • EU Integration office

Program Committee

  • Amira Deia Younes
    Amira Deia Younes Associate Director, Regulatory Policy and Intelligence, MEA, Russia & CEE
    Abbvie, United Arab Emirates
  • Ana  Petrovic
    Ana Petrovic Managing Director
    Association of Research-Based Medicine Producers in Bosnia & Herzegovina (UIPL), Bosnia and Herzegovina
  • Bojan  Trkulja
    Bojan Trkulja Managing Director
    The Association of the Manufacturers of Innovative Drugs – INOVIA, Serbia
  • Ivana  Ferber, MPharm, MS
    Ivana Ferber, MPharm, MS Regulatory Affairs Lead Croatia/Bosnia and Herzegovina
    Merck Sharp & Dohme, Croatia (Hrvatska)
  • Jelena  Simovic
    Jelena Simovic Regulatory Affairs Head
    Janssen Pharmaceutical Company of Johnson & Johnson, Serbia
  • Manuela  Stojanovic-Pejovski
    Manuela Stojanovic-Pejovski Executive Director
    Farmabrend Nova, North Macedonia
  • Melly  Lin, MS
    Melly Lin, MS Regional Policy Lead
    F. Hoffmann-La Roche Ltd, Switzerland
  • Sara  Torgal, MPharm
    Sara Torgal, MPharm Senior Manager, Scientific Programs
    DIA, Switzerland
  • Samvel  Azatyan, MD, PhD
    Samvel Azatyan, MD, PhD Team Lead, Regulatory Convergence and Networks (RCN/REG)
    World Health Organization (WHO), Switzerland
  • Angelika  Joos, MPharm
    Angelika Joos, MPharm Executive Director, Global Regulatory Policy
    Merck Sharp & Dohme (Europe) Inc., Belgium
  • Biljana  Tubic, DrSc
    Biljana Tubic, DrSc Head of Department of Medicinal Products
    Agency for Medicinal Products and Medical Devices (ALMBiH), Bosnia and Herzegovina
  • Jadranka  Mirkovic
    Jadranka Mirkovic Head of the Humane Medicines Centre
    Medicines and Medical Devices Agency of Serbia (ALIMS), Serbia
  • Maja  Lovrek Romcevic, MPharm
    Maja Lovrek Romcevic, MPharm Head of Medicines Authorisation Division
    Agency for Medicinal Products and Medical Devices, Croatia (Hrvatska)
  • Milena  Anicic
    Milena Anicic RA and QA Chapter Lead
    Roche, Serbia
  • Ranela  Ceci, PhD
    Ranela Ceci, PhD Specialist, Marketing Authorization and Regulatory Affairs Department
    National Agency For Medicinal Products and Medical Devices (AKBPM), Albania
Load More

Contact us

Registration Questions?

Send Email
+41 61 225 51 51

Digital Learning Catalog

DIA Learning: eLearning Soultions